In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Zimmer buys Centerpulse for $3.2bn

Executive Summary

In a move that trumped Smith & Nephew's March 2003 bid to acquire Centerpulse AG (formerly Sulzer Medica), Zimmer came in with an offer to buy the implantable device company for stock and cash valued at $3.2bn (CHF4.2bn). S&N backed out, leaving a Zimmer-Centerpulse merger that will create the world's largest pure-play orthopedics company.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Includes Contract
    • Payment Includes Cash
    • Payment Includes Stock

Related Companies